Does UPADACITINIB Cause Cholelithiasis? 173 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 173 reports of Cholelithiasis have been filed in association with UPADACITINIB (Rinvoq). This represents 0.3% of all adverse event reports for UPADACITINIB.
173
Reports of Cholelithiasis with UPADACITINIB
0.3%
of all UPADACITINIB reports
1
Deaths
96
Hospitalizations
How Dangerous Is Cholelithiasis From UPADACITINIB?
Of the 173 reports, 1 (0.6%) resulted in death, 96 (55.5%) required hospitalization, and 1 (0.6%) were considered life-threatening.
Is Cholelithiasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 173 reports have been filed with the FAERS database.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Cholelithiasis?
ADALIMUMAB (1,238)
OCTREOTIDE (641)
SEMAGLUTIDE (571)
METHOTREXATE (466)
TIRZEPATIDE (386)
PREDNISONE (346)
ETANERCEPT (345)
ACETAMINOPHEN (313)
LENALIDOMIDE (308)
CEFTRIAXONE (306)
Which UPADACITINIB Alternatives Have Lower Cholelithiasis Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL